Optimal Heart Rate Management for Patients on Beta Blockers

Clinical Application Guidelines

The American Heart Association recommends titrating beta blockers in cardiovascular patients to achieve a target heart rate of 50-60 bpm for optimal outcomes 1, 2
For perioperative patients, the American College of Cardiology suggests targeting a resting heart rate of 60-65 bpm when using beta blockers 3
An absolute mean perioperative heart rate lower than 70 bpm is associated with the best clinical outcomes, according to the American Heart Association 3

The American Heart Association advises that beta blocker therapy requires careful titration to avoid adverse effects like bradycardia and hypotension, with a risk ratio of 2.22 for bradycardia (95% CI 1.50 to 3.29) 4
The American College of Cardiology recommends holding beta blocker medication if heart rate drops below 50 bpm or systolic blood pressure falls below 100 mmHg 4
Abrupt discontinuation of beta blockers can lead to increased risk of adverse cardiac events, including MI (RR 2.70, 95% CI 1.06 to 6.89 within first 30 days after cessation), as reported by the American Heart Association 5
Each 10-bpm reduction in heart rate is estimated to reduce the relative risk of cardiac death by 30% in post-MI patients, highlighting the importance of appropriate heart rate control, according to the American Heart Association 1

Beta blockers should be continued in patients undergoing cardiac surgery who are already receiving beta blockers for treatment of conditions with ACCF/AHA Class I guideline indications such as angina, symptomatic arrhythmias, or hypertension, as recommended by the American College of Cardiology and American Heart Association 6, 7, 8

The American College of Cardiology recommends that beta blocker discontinuation is associated with dramatically increased cardiovascular mortality and increased postoperative MI risk, with a relative risk of 2.70, 95% CI 1.06 to 6.89 within the first 30 days 9

The American College of Cardiology advises against starting beta blockers on the day of surgery in beta-blocker-naïve patients, particularly at high doses or in long-acting formulations, as this approach has been associated with increased mortality and stroke 10, 11
The American College of Cardiology suggests that if initiating beta blockers preoperatively, they should be started at least 2-7 days before surgery to assess tolerability and clinical effectiveness 10
Starting beta blockers within 1 day or less before surgery prevents nonfatal MI but increases risks of stroke, death, hypotension, and bradycardia 11

The current consensus, as reported in the Journal of the American College of Cardiology, strongly supports continuation of existing beta blocker therapy in cardiac surgery patients, while being much more cautious about new initiation, with a risk ratio of 2.22 for bradycardia, 95% CI 1.50 to 3.29 10, 11, 12